EyePoint, Inc. (EYPT) stock
EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$0.23−0.03 (-11.36%)
Close on Nov 20, 2026Market cap $20.19MP/E –Yield –
EyePoint free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
EyePoint's free cash flow for the twelve months ending Jun 30, 2026 was -$271.28M. For fiscal 2025 it was -$243.39M. The highest annual figure on record is $10.14M in fiscal 2015.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$243.39M | – |
| FY2024 | Dec 31, 2024 | -$130.28M | – |
| FY2023 | Dec 31, 2023 | -$1.61M | – |
| FY2022 | Dec 31, 2022 | -$67.16M | – |
| FY2021 | Dec 31, 2021 | -$50.25M | – |
| FY2020 | Dec 31, 2020 | -$14.80M | – |
| FY2018 | Jun 30, 2018 | -$22.02M | – |
| FY2017 | Jun 30, 2017 | -$20.64M | – |
| FY2016 | Jun 30, 2016 | -$16.43M | -262.1% |
| FY2015 | Jun 30, 2015 | $10.14M | – |
| FY2014 | Jun 30, 2014 | -$10.92M | – |
| FY2013 | Jun 30, 2013 | -$8.81M | – |
| FY2012 | Jun 30, 2012 | -$9.41M | – |
| FY2011 | Jun 30, 2011 | -$3.30M | -133.4% |
| FY2010 | Jun 30, 2010 | $9.88M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$63.55M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$81.55M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$66.03M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$60.15M | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$63.81M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$53.40M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$36.23M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$40.60M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$21.08M | -137.2% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$32.37M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$23.99M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$16.92M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $56.63M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$17.32M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$13.17M | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$14.33M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$19.34M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$20.31M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$16.67M | -392.3% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -$7.92M | -885.5% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -$10.57M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$15.10M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $5.70M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $1.01M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$5.15M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$16.36M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$6.13M | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$4.82M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$5.04M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$6.03M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$4.58M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$4.56M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$5.01M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$6.49M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$4.39M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$4.33M | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -$3.20M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -$4.50M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | -$3.10M | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | -$4.00M | – |
See a number that looks wrong?